References
- Andrade RS, Heron DE, Degirmenci B, et al (2006). Post-treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys, 65, 1315-22. https://doi.org/10.1016/j.ijrobp.2006.03.015
- Bastiaannet E, Groen H, Jager PL, et al (2004). The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas: A systematic review and meta-analysis. Cancer Treat Rev, 30, 83-101. https://doi.org/10.1016/j.ctrv.2003.07.004
- De Santis M, Becherer A, Bokemeyer C, et al (2004). 2-[18]Fluoro- deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial. J Clin Oncol, 22, 1034-9. https://doi.org/10.1200/JCO.2004.07.188
- Ding M, Newman F, Raben D (2005). New radiation therapy techniques for the treatment of head and neck cancer. Otolaryngol Clin North Am, 38, 371-95. https://doi.org/10.1016/j.otc.2004.10.009
- Eisbruch A, Marsh LH, Dawson LA, et al (2004). Recurrences near base of skull after IMRT for head-and-neck cancer: Implica- tions for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys, 59, 28-42. https://doi.org/10.1016/j.ijrobp.2003.10.032
- El-Sayed S, Nelson N (1996). Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and random- ized trials. J Clin Oncol, 14, 838-47.
- Hain SF, O'Doherty MJ, Timothy AR, et al (2000). Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med, 27, 590-4 https://doi.org/10.1007/s002590050547
- HigginsKA, Hoang JK, Roach MC, et al (2012). Analysis of Pretreatment FDG-PET SUV parameters in Head-and-Neck Cancer: Tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys, 82, 548-53 https://doi.org/10.1016/j.ijrobp.2010.11.050
- Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observations. J Am Statist Assoc, 53, 457-81 https://doi.org/10.1080/01621459.1958.10501452
- Lee N, Xia P, Fischbein NJ, (2003). Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys, 57, 49-60. https://doi.org/10.1016/S0360-3016(03)00405-X
- Lefebvre JL, Chevalier D, Luboinski B, et al (1996). Larynx preservation in pyriform sinus cancer: Preliminary results of a Eu- ropean Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst, 88, 890-9. https://doi.org/10.1093/jnci/88.13.890
- Mantel N (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep, 5, 163-70
- Moeller BJ, Rana V, Cannon BA, et al (2009). Prospective risk-adjuste [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol, 20, 2509-15.
- Murphy JD, La TH, Chu K, et al (2011). Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys, 80, 514-21. https://doi.org/10.1016/j.ijrobp.2010.01.057
- Paccagnella A, Orlando A, Marchiori C, et al (1994). Phase III trial of initial chemotherapy in Stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst, 86, 265-72. https://doi.org/10.1093/jnci/86.4.265
- Paola Castaldi,Vittoria Rufini,Francesco Bussu, et al (2012). Can early and late 18F-FDG PET.CT be used as prognostic factors.for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? Radiother Oncol, 3, 63-8.
- Passero VA, Branstetter BF, Shuai Y, et al (2010). Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol, 21, 2278-83 https://doi.org/10.1093/annonc/mdq226
- Pfister DG, Shaha AR, Harrison LB (1997). The role of chemotherapy in the curative treatment of head and neck cancer. Surg Oncol Clin N Am, 6, 749-68
- Pignon JP, le Maitre A, Maillard E, Bourhis J, (2009). Meta-analysis of chemo- therapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17, 346 patients. Radiother Oncol, 92, 4-14. https://doi.org/10.1016/j.radonc.2009.04.014
- Prestwich RJ, Subesinghe M, Gilbert A, et al (2012). Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma. Clin Radiol, 67, 966-75. https://doi.org/10.1016/j.crad.2012.02.016
- Rose PG, Adler LP, Rodriguez M, et al (1999). Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study. J Clin Oncol, 17, 41-5.
- Scarfone C, Lavely WC, Cmelak AJ, et al (2004). Prospective feasibil- ity trial of radiotherapy target definition for head and neck can- cer using 3-dimensional PET and CT imaging. J Nucl Med, 45, 543-52.
- Schwartz DL, Ford E, Rajendran J, et al (2005). FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 61, 129-36. https://doi.org/10.1016/j.ijrobp.2004.03.040
- Trautmann TG, Zuger JH, (2005). Positron Emission Tomography for Pretreatment Staging and Posttreatment Evaluation in Cancer of the Anal Canal: Mol Imaging Biol, 7, 309-13. https://doi.org/10.1007/s11307-005-0003-6
- Troost EG, Schinagl DA, Bussink J, Oyen WJ, Kaanders JH (2010). Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours. Radiother Oncol, 96, 328-34. https://doi.org/10.1016/j.radonc.2010.07.017
- Wong RJ, Lin DT, Schoder H et al (2002). Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma. J Clin Oncol, 20, 4199-208. https://doi.org/10.1200/JCO.2002.02.590
- Yanagawa M, Tatsumi M, Miyata H, et al (2012). Evaluation of Response to Neoadjuvant Chemotherapy for Esophageal Cancer: PET Response Criteria in Solid Tumors Versus Response Evaluation Criteria in Solid Tumors. J Nucl Med, 53, 872-80. https://doi.org/10.2967/jnumed.111.098699
- Yao M, Smith RB, Graham MM, et al (2005). The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys, 63, 991-9 https://doi.org/10.1016/j.ijrobp.2005.03.066
Cited by
- Standardized Uptake Values Highly Correlate with Tumor Size and Fuhrman Grade in Patients with Clear Cell Renal Cell Carcinoma vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7821
- Risk of Cancer Mortality according to the Metabolic Health Status and Degree of Obesity vol.15, pp.22, 2014, https://doi.org/10.7314/APJCP.2014.15.22.10027
- Diagnostic Accuracy of 18F-FDG-PET in Patients with Testicular Cancer: a Meta-analysis vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3525